Estimation of walking distance in intermittent claudication: need for standardization.
نویسندگان
چکیده
Intermittent claudication is the most striking symptom of peripheral arterial occlusive disease, a disease mostly confined to the lower limb arteries and characterized by ischaemic processes in one or both legs and important reductions of the patients’ walking distance. In a large number of patients significant reduction of symptoms can be achieved by correction of associated risk factors, particularly smoking, and by (supervised) training programmes (walking). The treadmill is generally accepted as the reference method for evaluating severity of intermittent claudication and effects of treatment options. However, as yet there are no sound literature data to sustain these widely accepted indications. Ideally any standardization of a treadmill test should fulfil several criteria: simplicity and cheapness, no complications, a good reproducibility and predictive value and accuracy against a gold standard. Whether arteriography of the lower limb arteries constitutes the gold standard to assess severeness of arterial lesions remains a matter of debate. A recent review of all methodology used in the literature to measure claudication distance revealed that at present it is measured spuriously and inappropriately, is inaccurately reported and usually misinterpreted. We will limit ourselves to critical discussion of the evaluation of the walking distance by treadmill tests or alternatives. The following parameters can be derived from a treadmill test: (1) the claudication-free walking time or distance; (2) the maximal walking time or distance. We prefer to use the distance parameters, because this is more meaningful than considering walking time. The claudication-free distance is the distance that a claudicant can walk on the treadmill without pain in the limb(s). The pain-free walking or the initial claudication distance is another method of measuring the claudication-free walking distance. The maximal walking distance is the maximal distance that a claudicant can walk on a treadmill. Other terms for
منابع مشابه
Nordic poles immediately improve walking distance in patients with intermittent claudication.
OBJECTIVES To investigate the immediate effects of Nordic pole walking (NPW) on walking distance and cardiopulmonary workload in patients with intermittent claudication. METHODS Using a standardised treadmill test (3.2 km h(-1) at 4% gradient), walking distance, cardiopulmonary responses, leg pain and perceived exertion during NPW were compared to responses evoked by normal walking in 20 pati...
متن کاملExercise prescription using the heart of claudication pain onset in patients with intermittent claudication
OBJECTIVE To assess the acute metabolic and cardiovascular responses to walking exercise at an intensity corresponding to the heart rate of claudication pain onset and to investigate the effects of a 12-week walking training program at this intensity on walking capacity. METHODS Twenty-nine patients with intermittent claudication were randomly allocated to the walking training (n=17) or contr...
متن کاملPredictors of walking capacity in peripheral arterial disease patients
OBJECTIVE To estimate walking capacity in intermittent claudication patients through a prediction model based on clinical characteristics and the walking impairment questionnaire. METHODS The sample included 133 intermittent claudication patients of both genders aged between 30 and 80 years. Data regarding clinical characteristics, the walking impairment questionnaire and treadmill walking te...
متن کاملFunctional claudication distance: a reliable and valid measurement to assess functional limitation in patients with intermittent claudication
BACKGROUND Disease severity and functional impairment in patients with intermittent claudication is usually quantified by the measurement of pain-free walking distance (intermittent claudication distance, ICD) and maximal walking distance (absolute claudication distance, ACD). However, the distance at which a patient would prefer to stop because of claudication pain seems a definition that is m...
متن کاملPharmacological management of intermittent claudication: a meta-analysis of randomised trials.
Intermittent claudication, a symptom of atherosclerosis in the large vessels of the lower limbs, greatly affects patient mobility and quality of life. Medical therapy for a moderate form of this condition includes vasodilators, antiplatelet agents and alternative treatments such as ginkgo biloba.A meta-analysis of results from 52 trials (including 5088 patients) was conducted for all current me...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- European heart journal
دوره 20 9 شماره
صفحات -
تاریخ انتشار 1999